Sabra Health Care REIT (NASDAQ:SBRA) Releases Q1 Earnings Guidance


Share on StockTwits

Sabra Health Care REIT (NASDAQ:SBRA) updated its first quarter earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $0.38-0.39 for the period, compared to the Thomson Reuters consensus estimate of $0.43. Sabra Health Care REIT also updated its Q1 2021
After-Hours guidance to 0.38-0.39 EPS.

SBRA stock traded up $0.57 during midday trading on Monday, hitting $18.44. 1,811,491 shares of the stock were exchanged, compared to its average volume of 1,360,114. The stock’s 50-day moving average price is $17.42 and its 200-day moving average price is $16.08. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market cap of $3.82 billion, a price-to-earnings ratio of 26.73 and a beta of 1.49. Sabra Health Care REIT has a fifty-two week low of $5.55 and a fifty-two week high of $22.47.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 26th. Stockholders of record on Friday, February 12th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.51%. The ex-dividend date is Thursday, February 11th. Sabra Health Care REIT’s dividend payout ratio is currently 64.52%.

SBRA has been the topic of several recent research reports. TheStreet upgraded shares of Sabra Health Care REIT from a c+ rating to a b- rating in a research report on Tuesday, November 24th. JMP Securities raised shares of Sabra Health Care REIT from a market perform rating to an outperform rating and set a $24.00 price target on the stock in a report on Thursday, December 3rd. BMO Capital Markets raised shares of Sabra Health Care REIT from an underperform rating to a market perform rating and set a $19.00 price objective for the company in a research note on Thursday, January 7th. Smith Barney Citigroup lifted their price objective on Sabra Health Care REIT from $14.00 to $17.00 in a research report on Tuesday, December 15th. Finally, Mizuho cut Sabra Health Care REIT from a buy rating to a neutral rating and set a $18.00 target price on the stock. in a report on Wednesday, January 13th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $17.08.

About Sabra Health Care REIT

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.

Further Reading: What are the benefits of a portfolio tracker?

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.